Vaccinology

Vaccinology, Inc. is a biotechnology and consulting firm focused on the advancement of vaccine science through the application of vaccinomics and personalized medicine. Founded by Dr. Gregory Poland, a leading expert from the Mayo Clinic, the company leverages immunogenetics to understand individual variations in vaccine response and safety. Its business model encompasses both the development of novel vaccine candidates and providing strategic advisory services to major pharmaceutical companies and governmental organizations. By moving away from a "one size fits all" approach, Vaccinology aims to optimize vaccine efficacy and minimize adverse events through predictive modeling and genetic profiling. The company is a key player in the transition toward "Vaccinology 3.0," integrating artificial intelligence and systems biology into the vaccine development lifecycle.